Cargando…

FGF23 promotes prostate cancer progression

Prostate cancer is the most common cancer in US men and the second leading cause of cancer deaths. Fibroblast growth factor 23 (FGF23) is an endocrine FGF, normally expressed by osteocytes, which plays a critical role in phosphate homeostasis via a feedback loop involving the kidney and vitamin D. W...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Shu, Wang, Jianghua, Zhang, Yiqun, Creighton, Chad J., Ittmann, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627308/ https://www.ncbi.nlm.nih.gov/pubmed/26019137

Ejemplares similares

Function of phosphorylation of NF-kB p65 ser536 in prostate cancer oncogenesis
por: Zhang, Li, et al.
Publicado: (2015)

miR-33a is a tumor suppressor microRNA that is decreased in prostate cancer
por: Karatas, Omer Faruk, et al.
Publicado: (2017)

Fibroblast growth factor receptor signaling plays a key role in transformation induced by the TMPRSS2/ERG fusion gene and decreased PTEN
por: Shao, Longjiang, et al.
Publicado: (2018)

Combination treatment of prostate cancer with FGF receptor and AKT kinase inhibitors
por: Feng, Shu, et al.
Publicado: (2016)

Comparative and integrative analysis of transcriptomic and epigenomic-wide DNA methylation changes in African American prostate cancer
por: Creighton, Chad J., et al.
Publicado: (2023)

Stromal TGF-β signaling induces AR activation in prostate cancer
por: Yang, Feng, et al.
Publicado: (2014)

A dosage-dependent pleiotropic role of Dicer in prostate cancer growth and metastasis
por: Zhang, Boyu, et al.
Publicado: (2013)

Overexpression of FGF9 in Prostate Epithelial Cells Augments Reactive Stroma Formation and Promotes Prostate Cancer Progression
por: Huang, Yanqing, et al.
Publicado: (2015)

Macrophages promote the progression of premalignant mammary lesions to invasive cancer
por: Carron, Emily C., et al.
Publicado: (2017)

Frequent Heterogeneous Missense Mutations of GGAP2 in Prostate Cancer: Implications for Tumor Biology, Clonality and Mutation Analysis
por: Cai, Yi, et al.
Publicado: (2012)

miR-1 and miR-133b Are Differentially Expressed in Patients with Recurrent Prostate Cancer
por: Karatas, Omer Faruk, et al.
Publicado: (2014)

CKB inhibits epithelial-mesenchymal transition and prostate cancer progression by sequestering and inhibiting AKT activation
por: Wang, Zheng, et al.
Publicado: (2021)

FGF23 promotes myocardial fibrosis in mice through activation of β-catenin
por: Hao, Huixin, et al.
Publicado: (2016)

Phosphate and FGF-23
por: Jüppner, Harald
Publicado: (2011)

FGF23 and inflammation
por: Sharaf El Din, Usama A A, et al.
Publicado: (2017)

Increased Notch signaling inhibits anoikis and stimulates proliferation of prostate luminal epithelial cells
por: Kwon, Oh-Joon, et al.
Publicado: (2014)

FGF23 protects osteoblasts from dexamethasone-induced oxidative injury
por: Ji, Feng, et al.
Publicado: (2020)

FGF23 and Fetuin-A Interaction in the Liver and in the Circulation
por: Mattinzoli, Deborah, et al.
Publicado: (2018)

Role of Fibroblast Growth Factor 23 (FGF23) and αKlotho in Cancer
por: Ewendt, Franz, et al.
Publicado: (2021)

Dysregulation of miRNAs-COUP-TFII-FOXM1-CENPF axis contributes to the metastasis of prostate cancer
por: Lin, Shih-Chieh, et al.
Publicado: (2016)

The Suitability of FGF21 and FGF23 as New Biomarkers in Endometrial Cancer Patients
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2020)

Urinary tetrahydroaldosterone is associated with circulating FGF23 in kidney stone formers
por: Moor, Matthias B., et al.
Publicado: (2022)

The effect of nephrectomy on Klotho, FGF-23 and bone metabolism
por: Kakareko, Katarzyna, et al.
Publicado: (2017)

FGF-23 in bone biology
por: Wesseling-Perry, Katherine
Publicado: (2009)

FGF23, Biomarker or Target?
por: Rodelo-Haad, Cristian, et al.
Publicado: (2019)

Pleiotropic Actions of FGF23
por: Erben, Reinhold G.
Publicado: (2017)

FGF-23 associated with the progression of coronary artery calcification in hemodialysis patients
por: Ozkok, Abdullah, et al.
Publicado: (2013)

Pan-urologic cancer genomic subtypes that transcend tissue of origin
por: Chen, Fengju, et al.
Publicado: (2017)

Pan-cancer molecular subtypes of metastasis reveal distinct and evolving transcriptional programs
por: Zhang, Yiqun, et al.
Publicado: (2023)

Variation in the fibroblast growth factor 23 (FGF23) gene associates with serum FGF23 and bone strength in infants
por: Enlund-Cerullo, Maria, et al.
Publicado: (2023)

Systematic identification of non-coding somatic single nucleotide variants associated with altered transcription and DNA methylation in adult and pediatric cancers
por: Chen, Fengju, et al.
Publicado: (2021)

Prostate-specific loss of UXT promotes cancer progression
por: Wang, Yu, et al.
Publicado: (2019)

Correlation of Fgf23 and Balp with Bone Mineral Density in Hemodialysis Patients
por: Bouksila, Mouna, et al.
Publicado: (2019)

PKC regulates the production of fibroblast growth factor 23 (FGF23)
por: Bär, Ludmilla, et al.
Publicado: (2019)

FGF23 as a calciotropic hormone
por: Rodríguez-Ortiz, María E., et al.
Publicado: (2015)

FGF23 in Acute and Chronic Illness
por: Schnedl, Christian, et al.
Publicado: (2015)

FGF23 Producing Mesenchymal Tumor
por: Papierska, Lucyna, et al.
Publicado: (2014)

Role of FGF23 in Pediatric Hypercalciuria
por: Moreira Guimarães Penido, Maria Goretti, et al.
Publicado: (2017)

Paracrine Effects of FGF23 on the Heart
por: Leifheit-Nestler, Maren, et al.
Publicado: (2018)

FGF23, Hypophosphatemia, and Emerging Treatments
por: Imel, Erik A, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_q2mgrptvrv5n22r8chg02g5ooh